The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Did you miss ASH 2019? The Lymphoma Hub attended the 61st ASH Annual Meeting & Exposition, December 7-10 2019, Orlando, US, and has developed a downloadable resource on the practice-changing abstracts in lymphoma and CLL.

In this resource, you will find comments from the Lymphoma Hub Steering Committee members on DLBCL prognostic factors, MCL novel treatment options, FL chemo-free treatment options, treating patients with newly diagnosed CLL, R/R CLL, and poor-prognosis NHL, and the role of maintenance therapy in Waldenstrӧm’s macroglobulinemia.

Updated November 24, 2020. 

ASH 2019 | Practice-changing abstracts in lymphoma and CLL

If you would like to view the practice-changing abstracts from ASH 2019 and the expert opinions from our Steering Committee, please download the resource below.

Download Here